| 1 |
34162690 | Comparative Hepatic and Intestinal Efflux Transport of Statins. | 2021 Sep |
2 |
| 2 |
30339864 | The Impact of Endogenous Breast Cancer Resistance Protein on Human P-Glycoprotein-Mediated Transport Assays Using LLC-PK1 Cells Transfected With Human P-Glycoprotein. | 2019 Mar |
1 |
| 3 |
24024895 | CYP2C9 and ABCG2 polymorphisms as risk factors for developing adverse drug reactions in renal transplant patients taking fluvastatin: a case-control study. | 2013 Sep |
3 |
| 4 |
22941809 | CYP2C9*3(1075A>C), MDR1 G2677T/A and MDR1 C3435T are determinants of inter-subject variability in fluvastatin pharmacokinetics in healthy Chinese volunteers. | 2012 Nov |
1 |
| 5 |
21447733 | Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs. | 2011 Jul |
1 |
| 6 |
19842935 | Different effects of the ABCG2 c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin. | 2009 Oct |
3 |